BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 21906430)

  • 1. Advanced glycation end products affect growth and function of osteoblasts.
    Franke S; Rüster C; Pester J; Hofmann G; Oelzner P; Wolf G
    Clin Exp Rheumatol; 2011; 29(4):650-60. PubMed ID: 21906430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells.
    Franke S; Sommer M; Rüster C; Bondeva T; Marticke J; Hofmann G; Hein G; Wolf G
    Arthritis Res Ther; 2009; 11(5):R136. PubMed ID: 19735566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts.
    Franke S; Siggelkow H; Wolf G; Hein G
    Arch Physiol Biochem; 2007 Jun; 113(3):154-61. PubMed ID: 17922311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts.
    Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N
    Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamins D3 and K2 may partially counterbalance the detrimental effects of pentosidine in ex vivo human osteoblasts.
    Sanguineti R; Monacelli F; Parodi A; Furfaro AL; Borghi R; Pacini D; Pronzato MA; Odetti P; Molfetta L; Traverso N
    J Biol Regul Homeost Agents; 2016; 30(3):713-726. PubMed ID: 27655488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
    Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
    J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK.
    Tanikawa T; Okada Y; Tanikawa R; Tanaka Y
    J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
    Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
    Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99Tc-MDP-induced human osteoblast proliferation, differentiation and expression of osteoprotegerin.
    Chen J; Lan Y; He Y; He C; Xu F; Zhang Y; Zhao Y; Liu Y
    Mol Med Rep; 2017 Aug; 16(2):1801-1809. PubMed ID: 28656306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commensal Microbiota Enhance Both Osteoclast and Osteoblast Activities.
    Uchida Y; Irie K; Fukuhara D; Kataoka K; Hattori T; Ono M; Ekuni D; Kubota S; Morita M
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29937485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells.
    Li F; Yang Y; Zhu P; Chen W; Qi D; Shi X; Zhang C; Yang Z; Li P
    Fitoterapia; 2012 Dec; 83(8):1443-50. PubMed ID: 22951288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of TNF-α, GSK-3β and RANKL in the occurrence and development of diabetic osteoporosis.
    Qi J; Hu KS; Yang HL
    Int J Clin Exp Pathol; 2015; 8(10):11995-2004. PubMed ID: 26722385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of advanced glycation end-products and Porphyromonas gingivalis lipopolysaccharide on the expression of osteoblastic markers of rat bone marrow cells in culture.
    Sakamoto E; Mihara C; Ikuta T; Inagaki Y; Kido J; Nagata T
    J Periodontal Res; 2016 Jun; 51(3):313-20. PubMed ID: 26223811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Butyrate Stimulates Histone H3 Acetylation, 8-Isoprostane Production, RANKL Expression, and Regulated Osteoprotegerin Expression/Secretion in MG-63 Osteoblastic Cells.
    Chang MC; Chen YJ; Lian YC; Chang BE; Huang CC; Huang WL; Pan YH; Jeng JH
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30562925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low doses of Co nanoparticles induce death and regulate osteogenic differentiation in MG‑63 cells.
    Han Q; Liu F
    Mol Med Rep; 2017 Nov; 16(5):7591-7596. PubMed ID: 28944833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha.
    Lohwasser C; Neureiter D; Weigle B; Kirchner T; Schuppan D
    J Invest Dermatol; 2006 Feb; 126(2):291-9. PubMed ID: 16374460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteogenic differentiation of periodontal fibroblasts is dependent on the strength of mechanical strain.
    Jacobs C; Grimm S; Ziebart T; Walter C; Wehrbein H
    Arch Oral Biol; 2013 Jul; 58(7):896-904. PubMed ID: 23422327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression.
    Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
    Pharmacol Res; 2010 Jan; 61(1):34-9. PubMed ID: 19635564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.